Investor Relations
Financial Calendar
- 08/02/24
Year-end report, 2023
Latest press releases
ExpreS2ion announces new EU-funded Horizon Europe grant award for Nipah virus vaccine development
Regulatory pressreleaseHørsholm, Denmark, 1 December 2023 – ExpreS[2]ion Biotech Holding AB’s affiliate ExpreS[2]ion Biotechnologies ApS (“ExpreS2ion") today announces the award of a Horizon Europe grant amounting to 8 million EUR, approximately 90 million SEK, to the VICI-Disease consortium, of which 53% is direct contribution for ExpreS2ion’s part of the project costs. The aim is to obtain…
Read moreExpreS2ion CEO interviewed, CFO provides update at life science investor conference, Analysguiden publishes research report
Non-regulatory pressreleaseHørsholm, Denmark, 27 November 2023 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that ExpreS2ion CEO Bent Frandsen participated in a Finwire interview, CFO Keith Alexander participated in the Økonomisk Ugebrev Life Science Investor Conference on 22 November, and Analysguiden has published a research report on ExpreS2ion in November.
Read more